Accuri C6 Flow Cytometer System
Originally published online as doi:10.1189/jlb.1208745 on April 20, 2009

Published online before print April 20, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Buy
Right arrow All Versions of this Article:
jlb.1208745v1
86/1/91    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seth, S.
Right arrow Articles by Bernhardt, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seth, S.
Right arrow Articles by Bernhardt, G.
(Journal of Leukocyte Biology. 2009;86:91-101.)
© 2009 Society for Leukocyte Biology

Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cells

Sebastian Seth*, Anna-Maria Georgoudaki{dagger}, Benedict J. Chambers{dagger}, Quan Qiu*, Elisabeth Kremmer{ddagger}, Michael K. Maier*, Niklas Czeloth*, Inga Ravens*, Reinhold Foerster* and Günter Bernhardt*,1

* Institute of Immunology, Hannover Medical School, Hannover, Germany;
{dagger} Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden; and
{ddagger} Institute of Molecular Immunology, Helmholtz Zentrum München, Munich, Germany

1. Correspondence: Institute of Immunology, Hannover Medical School, Carl-Neuberg Str. 1, 30625 Hannover, Germany. E-mail: bernhardt.guenter{at}mh-hannover.de

ABSTRACT

The adhesion receptor CD226 (DNAM-1) is a member of the Ig superfamily possessing two extracellular V-like domains. In humans, CD226 was shown to be expressed by NK as well as T cells. During T cell priming, CD226-mediated costimulatory signals may skew the subsequent differentiation into the Th1 pathway. In addition, CD226 expressed on NK and cytotoxic T cells is engaged by its counter-receptor CD155, present on target cells, thereby triggering their elimination. We established mAb specifically recognizing mCD226, demonstrating that CD226 is expressed by precursor and mature but not developing T cells. In contrast, NK cells are distinguished by a rather heterogeneous CD226 expression profile. In addition, expression of CD226 appears coupled to that of other NK cell receptors, as high expression of CD226 was found to correlate with decreased proportions of Ly49D and H positive NK cells. Upon injection into mice, the anti-CD226 antibodies caused selective depletion of CD8+ T cells. Moreover, these antibodies as well as a naturally occurring CD226 splice variant lacking the outermost V-like domain were instrumental in determining that CD226 adheres to CD155 via its first domain. In addition, antibodies were identified as capable of blocking the CD226/CD155 interaction and to prevent NK-driven killing of immature DC. CD226 is thus the first mNK receptor identified to be essential for the elimination of this particular cell type.

Key Words: DNAM-1 • CD155 • depletion • splice variant • antibodies




This article has been cited by other articles:


Home page
 J. Immunol.Home page
Q. Qiu, I. Ravens, S. Seth, A. Rathinasamy, M. K. Maier, A. Davalos-Misslitz, R. Forster, and G. Bernhardt
CD155 Is Involved in Negative Selection and Is Required To Retain Terminally Maturing CD8 T Cells in Thymus
J. Immunol., February 15, 2010; 184(4): 1681 - 1689.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. J. Chan, D. M. Andrews, N. M. McLaughlin, H. Yagita, S. Gilfillan, M. Colonna, and M. J. Smyth
DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases
J. Immunol., January 15, 2010; 184(2): 902 - 911.
[Abstract] [Full Text] [PDF]